ACS Early Rule Out Pathway Tool
Enter clinical and assay values
Use values and thresholds validated for the specific high-sensitivity troponin assay used by your laboratory.
Clinical context
High-sensitivity cardiac troponin (hs-cTn) is the preferred biomarker for evaluating suspected acute myocardial infarction. Validated clinical decision pathways use assay-specific concentrations and changes over a defined sampling interval, interpreted alongside symptoms and ECG findings.
This page compares the entered values with thresholds supplied by the user. It is a configurable screening aid, not a validated standalone 0/1-hour algorithm, and it must not be used by itself to discharge a patient or diagnose myocardial infarction.
Important interpretation points
- A value above the 99th-percentile upper reference limit indicates myocardial injury, but does not by itself establish myocardial infarction.
- Acute myocardial infarction requires a rise and/or fall in cardiac troponin with at least one value above the 99th percentile plus clinical evidence of acute myocardial ischaemia.
- Assay-specific algorithms have distinct baseline and delta thresholds. A generic threshold combination cannot reproduce all validated pathways.
- Use the ECG, clinical presentation, haemodynamic status, symptom recurrence, comorbidities, and local protocol. Persistent suspicion may require further sampling even after a low initial result.
- Do not delay urgent management for suspected STEMI or an unstable patient while awaiting this calculation.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.